Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Shigdar

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Letters|April 6, 2016
Challenges and opportunities for siRNA-based cancer treatmentTao Wang, Sarah Shigdar, Hadi Al Shamaileh, et al.
The Prostate|March 12, 2014
CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistanceJie Ni, Paul J Cozzi, Jing L Hao, et al.
Sensors (Basel, Switzerland)|October 25, 2013
Aptamers as theranostic agents: modifications, serum stability and functionalisationSarah Shigdar, Joanna Macdonald, Michael O'Connor, et al.
Scientific Reports|July 21, 2017
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cellsHadi AlShamaileh, Tao Wang, Dongxi Xiang, et al.
Theranostics|July 23, 2015
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid TumorsDongxi Xiang, Conglong Zheng, Shu-Feng Zhou, et al.
Theranostics|December 19, 2015
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer ModelTao Wang, Michael P Gantier, Dongxi Xiang, et al.
Theranostics|November 22, 2017
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated deliveryDongxi Xiang, Sarah Shigdar, Andrew G Bean, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Letters|April 6, 2016
Challenges and opportunities for siRNA-based cancer treatmentTao Wang, Sarah Shigdar, Hadi Al Shamaileh, et al.
The Prostate|March 12, 2014
CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistanceJie Ni, Paul J Cozzi, Jing L Hao, et al.
Sensors (Basel, Switzerland)|October 25, 2013
Aptamers as theranostic agents: modifications, serum stability and functionalisationSarah Shigdar, Joanna Macdonald, Michael O'Connor, et al.
Scientific Reports|July 21, 2017
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cellsHadi AlShamaileh, Tao Wang, Dongxi Xiang, et al.
Theranostics|July 23, 2015
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid TumorsDongxi Xiang, Conglong Zheng, Shu-Feng Zhou, et al.
Theranostics|December 19, 2015
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer ModelTao Wang, Michael P Gantier, Dongxi Xiang, et al.
Theranostics|November 22, 2017
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated deliveryDongxi Xiang, Sarah Shigdar, Andrew G Bean, et al.
Pageof 6